Nabilakhyar (Talk | contribs) |
Nabilakhyar (Talk | contribs) |
||
Line 75: | Line 75: | ||
<p style="text-align: center;"><strong>Figure 2 </strong>The fluorescent intensity of PHA produced with different glucose concentrations. (48 hours cultivation). Error bars represented standard deviations.</p> | <p style="text-align: center;"><strong>Figure 2 </strong>The fluorescent intensity of PHA produced with different glucose concentrations. (48 hours cultivation). Error bars represented standard deviations.</p> | ||
<p> </p> | <p> </p> | ||
− | <p style= "text align:center;"><strong>Table 1</strong> Yield of PHA of pSB1C3-phaCAB with different glucose concentrations</p> | + | <p style="text-align:center;"><strong>Table 1</strong> Yield of PHA of pSB1C3-phaCAB with different glucose concentrations</p> |
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/parts/8/81/T--Edinburgh_OG--2018--mingowen1.png" /> | <p><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/parts/8/81/T--Edinburgh_OG--2018--mingowen1.png" /> | ||
<p> </p> | <p> </p> | ||
Line 92: | Line 92: | ||
<ul> | <ul> | ||
<li style="text-align: justify;">Masani, M.Y.A., Parveez, G.K.A. and Izawati, A.M.D. 2009. Construction of PHB and PHBV multiple-gene vectors driven by an oil palm leaf-specific promoter. <em>Plasmid</em>, , 62(3), pp.191-200.</li> | <li style="text-align: justify;">Masani, M.Y.A., Parveez, G.K.A. and Izawati, A.M.D. 2009. Construction of PHB and PHBV multiple-gene vectors driven by an oil palm leaf-specific promoter. <em>Plasmid</em>, , 62(3), pp.191-200.</li> | ||
− | + | </ul> | |
Line 120: | Line 120: | ||
<p style="text-align: justify;">All the gene fragments with different overhangs were amplified by PCR amplification. Then Gibson Master Mix was used to assemble all the fragments and build constructs in new gene orders.</p> | <p style="text-align: justify;">All the gene fragments with different overhangs were amplified by PCR amplification. Then Gibson Master Mix was used to assemble all the fragments and build constructs in new gene orders.</p> | ||
<p><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/d/d8/T--Edinburgh_OG--PHBV_prodxn_-_2.png" /> | <p><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/d/d8/T--Edinburgh_OG--PHBV_prodxn_-_2.png" /> | ||
− | <p style="text-align: center;"><strong>Figure | + | <p style="text-align: center;"><strong>Figure 1 </strong>The workflow of Gibson assembly - Fragments are amplified with overlap, followed by incubation at 50˚C for 15-60 min, with Gibson Assembly Master Mix, which includes three essential enzymes (5´ exonuclease, DNA polymerase and DNA ligase). Those essential enzymes enable new construct to be assembled (Chan).</p> |
<p> </p> | <p> </p> | ||
<li><strong>PHB production confirmation and measurement</strong></li> | <li><strong>PHB production confirmation and measurement</strong></li> | ||
Line 129: | Line 129: | ||
<p style="text-align: justify;">Four constructs including <em>phaCAB</em>, <em>phaCBA</em>, <em>phaACB</em> and <em>phaBCA</em> were successfully constructed while the establishment of <em>phaACB</em> and <em>phaBAC</em> failed due to the inappropariate primers design. <strong> </strong>Nile red plate staining confirmed PHB production from cells that harboured four new constructs (<em>phaCAB</em>, <em>phaCBA</em>, <em>phaACB</em> and <em>phaBCA</em>). By measuring the yield of produced PHB, the most balanced PHB production is from <em>E. coli</em> that harboured original <em>phaCAB </em> operon and <em>phaACB</em> operon.</p> | <p style="text-align: justify;">Four constructs including <em>phaCAB</em>, <em>phaCBA</em>, <em>phaACB</em> and <em>phaBCA</em> were successfully constructed while the establishment of <em>phaACB</em> and <em>phaBAC</em> failed due to the inappropariate primers design. <strong> </strong>Nile red plate staining confirmed PHB production from cells that harboured four new constructs (<em>phaCAB</em>, <em>phaCBA</em>, <em>phaACB</em> and <em>phaBCA</em>). By measuring the yield of produced PHB, the most balanced PHB production is from <em>E. coli</em> that harboured original <em>phaCAB </em> operon and <em>phaACB</em> operon.</p> | ||
<p> </p> | <p> </p> | ||
− | <p style="text-align: center;"><strong>Table | + | <p style="text-align: center;"><strong>Table 1 </strong>The yield of produced PHB</p> |
<table style="margin-left: auto; margin-right: auto; width: 620.5px;"> | <table style="margin-left: auto; margin-right: auto; width: 620.5px;"> | ||
<tbody> | <tbody> | ||
Line 224: | Line 224: | ||
<h3 style="text-align: justify;"><strong>References</strong> </h3> | <h3 style="text-align: justify;"><strong>References</strong> </h3> | ||
+ | <ul> | ||
<li>Geyer, R., Jambeck, J.R. and Law, K.L., 2017. Production, use, and fate of all plastics ever made. <em>Science advances</em>, 3(7), p.e1700782.</li> | <li>Geyer, R., Jambeck, J.R. and Law, K.L., 2017. Production, use, and fate of all plastics ever made. <em>Science advances</em>, 3(7), p.e1700782.</li> | ||
<li>Bonartsev, A.P., Zharkova, I.I., Yakovlev, S.G., Myshkina, V.L., Mahina, T.K., Voinova, V.V., Zernov, A.L., Zhuikov, V.A., Akoulina, E.A., Ivanova, E.V. and Kuznetsova, E.S., 2017. Biosynthesis of poly (3-hydroxybutyrate) copolymers by Azotobacter chroococcum 7B: A precursor feeding strategy. <em>Preparative Biochemistry and Biotechnology</em>, 47(2), pp.173-184.</li> | <li>Bonartsev, A.P., Zharkova, I.I., Yakovlev, S.G., Myshkina, V.L., Mahina, T.K., Voinova, V.V., Zernov, A.L., Zhuikov, V.A., Akoulina, E.A., Ivanova, E.V. and Kuznetsova, E.S., 2017. Biosynthesis of poly (3-hydroxybutyrate) copolymers by Azotobacter chroococcum 7B: A precursor feeding strategy. <em>Preparative Biochemistry and Biotechnology</em>, 47(2), pp.173-184.</li> | ||
Line 242: | Line 243: | ||
<h4 style=" font-size:150% " ">Improvement of PHBV production by introducing <em>bktB</em> to <em>E. coli</em></h4> | <h4 style=" font-size:150% " ">Improvement of PHBV production by introducing <em>bktB</em> to <em>E. coli</em></h4> | ||
− | <p style="text-align: justify;">In this study, we constructed a PHBV synthesis pathway (shown in Figure | + | <p style="text-align: justify;">In this study, we constructed a PHBV synthesis pathway (shown in Figure 1) by introducing the <em>phaA</em>, <em>phaB</em> and <em>phaC</em> genes into <em>E. coli</em> BL21 (DE3). In order to enhance the 3HV fraction in PHBV, paralog <em>bktB</em> was introduced into <em>E. coli</em> BL21 (DE3) with co-expression of <em>phaCAB</em> operon from <em>Ralstonia eutropha</em>. And the effect of <em>bktB</em> on PHBV synthesis was further investigated by replacing <em>phaA </em>with <em>bktB. </em>With the cell culture condition optimisation, 3 % glucose and 8 mM propionic acid was proper feeding strategy for PHBV production. Cells harbouring pSB1C3-<em>phaCB</em>-<em>bktB</em> showed great potential to improve production of PHBV with higher 3HV fraction.</p> |
Line 250: | Line 251: | ||
<p><strong><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/7/76/T--Edinburgh_OG--PHBV_prodxn_-_3.png" width="689" height="130" /></strong></p> | <p><strong><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/7/76/T--Edinburgh_OG--PHBV_prodxn_-_3.png" width="689" height="130" /></strong></p> | ||
− | <p style="text-align: center;"><strong>Figure | + | <p style="text-align: center;"><strong>Figure 1 </strong>Schematic illustration of the pathways leading to the PHBV biosynthesis</p> |
<h3><strong>Background</strong></h3> | <h3><strong>Background</strong></h3> | ||
<p style="text-align: justify;">As a typical role in the PHAs family, poly(3-hydroxybutyrate-co-3- hydroxyvalerate) (PHBV) is more likely to be a potential candidate for thermoplastic because of its higher thermal stability and flexibility which could be optimised by adjusting 3-hydroxyvalerate (3HV) fractions (Yu et al., 2005). <em>Escherichia coli</em> is one of the best-studied bacteria and is used as an ideal host for PHB and PHBV production because of its well-studied genetics and metabolism. In addition, a high-cell-density cultivation strategy contributed to improve polymer yield and productivity (Shojaosadati et al., 2008). Whole genome analysis of <em>R. eutropha</em> H16 identified several genes as paralogous to the <em>phaA</em>, and the <em>bktB</em> was isolated from <em>R. eutropha</em> H16 as the most important paralogous gene for PHBV production since it showed higher substrate specificity to the C5 monomer and used 3-ketovaleryl-CoA more efficiently (Mifune et al., 2010). </p> | <p style="text-align: justify;">As a typical role in the PHAs family, poly(3-hydroxybutyrate-co-3- hydroxyvalerate) (PHBV) is more likely to be a potential candidate for thermoplastic because of its higher thermal stability and flexibility which could be optimised by adjusting 3-hydroxyvalerate (3HV) fractions (Yu et al., 2005). <em>Escherichia coli</em> is one of the best-studied bacteria and is used as an ideal host for PHB and PHBV production because of its well-studied genetics and metabolism. In addition, a high-cell-density cultivation strategy contributed to improve polymer yield and productivity (Shojaosadati et al., 2008). Whole genome analysis of <em>R. eutropha</em> H16 identified several genes as paralogous to the <em>phaA</em>, and the <em>bktB</em> was isolated from <em>R. eutropha</em> H16 as the most important paralogous gene for PHBV production since it showed higher substrate specificity to the C5 monomer and used 3-ketovaleryl-CoA more efficiently (Mifune et al., 2010). </p> | ||
Line 260: | Line 261: | ||
<p><em>E. coli</em> strain BL21 (DE3) that harboured these two plasmids was spread on the Nile red agar plates with negative control (pSB1C3) respectively, and the two plates were exposed to blue light. Compared with negative control, strong Nile red fluorescence observed from strains that harboured either pSB1C3-<em>phaCAB</em>-<em>bktB</em> or pSB1C3-<em>phaCB</em>-<em>bktB</em> indicated that PHA (PHB and PHBV) production was assessed after 24 hours.</p> | <p><em>E. coli</em> strain BL21 (DE3) that harboured these two plasmids was spread on the Nile red agar plates with negative control (pSB1C3) respectively, and the two plates were exposed to blue light. Compared with negative control, strong Nile red fluorescence observed from strains that harboured either pSB1C3-<em>phaCAB</em>-<em>bktB</em> or pSB1C3-<em>phaCB</em>-<em>bktB</em> indicated that PHA (PHB and PHBV) production was assessed after 24 hours.</p> | ||
<p><img src="https://2018.igem.org/File:T--Edinburgh_OG--PHBV_prodxn_-_nile_red_agar_plate_detection.png" alt="" /><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/f/f1/T--Edinburgh_OG--PHBV_prodxn_-_nile_red_agar_plate_detection.png" width="529" height="270" /></p> | <p><img src="https://2018.igem.org/File:T--Edinburgh_OG--PHBV_prodxn_-_nile_red_agar_plate_detection.png" alt="" /><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/f/f1/T--Edinburgh_OG--PHBV_prodxn_-_nile_red_agar_plate_detection.png" width="529" height="270" /></p> | ||
− | <p style="text-align: center;"><strong>Figure | + | <p style="text-align: center;"><strong>Figure 2 </strong>Nile red agar plate detection of PHA production - Paralogous gene <em>bktB</em> represented similar function with <em>phaA</em> gene in the pathway, which showed higher specificity to C5 monomers contributed to the PHBV productivity and 3HV fraction. Although Gas Chromatography remained to be done to analyse PHBV composition, lower melting temperature still gave strong suggestion that replacing <em>phaA</em> gene with <em>bktB</em> could significantly increase the PHBV content in PHA production and co-expression of two genes would show small increase of PHBV production. Combined with the culture condition optimisation, cells harbouring pSB1C3-<em>phaCB</em>-<em>bktB </em>showed great potential to improve production of PHBV with higher 3HV fraction.</p> |
<p? </p> | <p? </p> | ||
− | <p style="text-align: center;"><strong>Table | + | <p style="text-align: center;"><strong>Table 1 </strong>Melting temperatures of PHA from various sources</p> |
<table style="margin-left: auto; margin-right: auto;" width="0"> | <table style="margin-left: auto; margin-right: auto;" width="0"> | ||
<tbody> | <tbody> | ||
Line 368: | Line 369: | ||
<p>Gas chromatography remains to be executed to give more specific information about the composition of extracted PHA products including the percentage of PHBV content and the fraction of 3HV in PHBV, which are essential for confirming the effect of <em>bktB</em> on PHBV production.</p> | <p>Gas chromatography remains to be executed to give more specific information about the composition of extracted PHA products including the percentage of PHBV content and the fraction of 3HV in PHBV, which are essential for confirming the effect of <em>bktB</em> on PHBV production.</p> | ||
<h3><strong>References</strong></h3> | <h3><strong>References</strong></h3> | ||
− | + | <ul> | |
<li>Yu, S.T., Lin, C.C. and Too, J.R., 2005. PHBV production by <em>Ralstonia eutropha</em> in a continuous stirred tank reactor. <em>Process Biochemistry</em>, 40(8), pp.2729-2734.</li> | <li>Yu, S.T., Lin, C.C. and Too, J.R., 2005. PHBV production by <em>Ralstonia eutropha</em> in a continuous stirred tank reactor. <em>Process Biochemistry</em>, 40(8), pp.2729-2734.</li> | ||
<li>Shojaosadati, S.A., Varedi Kolaei, S.M., Babaeipour, V. and Farnoud, A.M., 2008. Recent advances in high cell density cultivation for production of recombinant protein. <em>Iranian Journal of Biotechnology</em>, 6(2), pp.63-84.</li> | <li>Shojaosadati, S.A., Varedi Kolaei, S.M., Babaeipour, V. and Farnoud, A.M., 2008. Recent advances in high cell density cultivation for production of recombinant protein. <em>Iranian Journal of Biotechnology</em>, 6(2), pp.63-84.</li> | ||
<li>Mifune, J., Nakamura, S. and Fukui, T., 2010. Engineering of pha operon on <em>Cupriavidus necator</em> chromosome for efficient biosynthesis of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) from vegetable oil. <em>Polymer Degradation and Stability</em>, 95(8), pp.1305-1312.</li> | <li>Mifune, J., Nakamura, S. and Fukui, T., 2010. Engineering of pha operon on <em>Cupriavidus necator</em> chromosome for efficient biosynthesis of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) from vegetable oil. <em>Polymer Degradation and Stability</em>, 95(8), pp.1305-1312.</li> | ||
− | + | </ul> | |
</div> | </div> | ||
</div> | </div> | ||
Line 404: | Line 405: | ||
<h3><strong>Results and Discussion</strong></h3> | <h3><strong>Results and Discussion</strong></h3> | ||
<p style="text-align: justify;">The stop codon between <em>phaP</em> and <em>hlyA</em> was removed forming a part for new Biobrick that could be submitted to the iGEM registry. The results obtained from cell viability assay demonstrated that the expression of <em>phaCAB</em> operon was likely to pose extra pressure on cells, while the regulation of <em>PhaR</em> and phasin can release the burden in some extent. The PHB produced by <em>E. coli</em> that harboured pSB3T5-<em>ProR</em>-<em>phaR</em>-<em>ProP</em>-<em>phaP</em>-<em>hlyA</em> is the highest. And the comparison of PHB yield listed below, indicating that the presence of <em>PhaR</em> regulator effectively regulate the expression of phasin and moderate the biosynthesis of PHB.</p> | <p style="text-align: justify;">The stop codon between <em>phaP</em> and <em>hlyA</em> was removed forming a part for new Biobrick that could be submitted to the iGEM registry. The results obtained from cell viability assay demonstrated that the expression of <em>phaCAB</em> operon was likely to pose extra pressure on cells, while the regulation of <em>PhaR</em> and phasin can release the burden in some extent. The PHB produced by <em>E. coli</em> that harboured pSB3T5-<em>ProR</em>-<em>phaR</em>-<em>ProP</em>-<em>phaP</em>-<em>hlyA</em> is the highest. And the comparison of PHB yield listed below, indicating that the presence of <em>PhaR</em> regulator effectively regulate the expression of phasin and moderate the biosynthesis of PHB.</p> | ||
− | <p style="text-align: center;"> <strong>Table | + | <p style="text-align: center;"> <strong>Table 1 </strong>The yield of PHB production</p> |
<table style="margin-left: auto; margin-right: auto; width: 820px;"> | <table style="margin-left: auto; margin-right: auto; width: 820px;"> | ||
<tbody> | <tbody> | ||
Line 532: | Line 533: | ||
<p> </p> | <p> </p> | ||
<h3><strong>References</strong></h3> | <h3><strong>References</strong></h3> | ||
+ | <ul> | ||
<li>York, G.M., Stubbe, J. and Sinskey, A.J., 2001. New insight into the role of the <em>PhaP</em> phasin of <em>Ralstonia eutropha</em> in promoting synthesis of polyhydroxybutyrate. <em>Journal of Bacteriology</em>, 183(7), pp.2394-2397.</li> | <li>York, G.M., Stubbe, J. and Sinskey, A.J., 2001. New insight into the role of the <em>PhaP</em> phasin of <em>Ralstonia eutropha</em> in promoting synthesis of polyhydroxybutyrate. <em>Journal of Bacteriology</em>, 183(7), pp.2394-2397.</li> | ||
<li>Pötter, M., Madkour, M.H., Mayer, F. and Steinbüchel, A., 2002. Regulation of phasin expression and polyhydroxyalkanoate (PHA) granule formation in <em>Ralstonia eutropha</em> H16. <em>Microbiology</em>, 148(8), pp.2413-2426.</li> | <li>Pötter, M., Madkour, M.H., Mayer, F. and Steinbüchel, A., 2002. Regulation of phasin expression and polyhydroxyalkanoate (PHA) granule formation in <em>Ralstonia eutropha</em> H16. <em>Microbiology</em>, 148(8), pp.2413-2426.</li> | ||
<li>Mergulhao, F.J.M., Summers, D.K. and Monteiro, G.A., 2005. Recombinant protein secretion in <em>Escherichia coli</em>. <em>Biotechnology advances</em>, 23(3), pp.177- 202.</li> | <li>Mergulhao, F.J.M., Summers, D.K. and Monteiro, G.A., 2005. Recombinant protein secretion in <em>Escherichia coli</em>. <em>Biotechnology advances</em>, 23(3), pp.177- 202.</li> | ||
− | + | </ul> | |
</div> | </div> | ||
Line 548: | Line 550: | ||
<h4 style=" font-size:150% " ">Construction of plasmids harbouring the Sleeping Beauty Mutase operon, and methylmalonyl CoA epimerase for producing propionate for PHBV production</h4> | <h4 style=" font-size:150% " ">Construction of plasmids harbouring the Sleeping Beauty Mutase operon, and methylmalonyl CoA epimerase for producing propionate for PHBV production</h4> | ||
− | <p style="text-align: justify;">Methylmalonyl-CoA Epimerase (MCE) was introduced in the proposed pathway (as shown in Figure | + | <p style="text-align: justify;">Methylmalonyl-CoA Epimerase (MCE) was introduced in the proposed pathway (as shown in Figure 1) resulting to high production of propionate. By expressing the Sleeping Beauty Mutase (SBM) operon and MCE with genes for PHA production in <em>E. coli</em> would result in the production of PHBV with a high ratio of valerate to butyrate. In this study, vectors harbouring the SBM operon with and without MCE was achieved.</p> |
Line 558: | Line 560: | ||
<p style="text-align: justify;">There are many bio-based alternatives to the widely used petrochemical-based plastics, which are degradable and therefore are less damaging to the environment, and to health. One such ‘bio-plastic’ are polyhydroxyalkanoates (PHAs), which is a large family with a huge range of properties. However, only one type of microbe produced PHA is affordable – poly(3- hydroxybutyrate) (PHB) – but too brittle for widespread use. PHA co-polymers, such as poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) are more flexible, and could fill niches that PHB does not. However, producing PHBV by microbes typically needs propionate to be supplied exogenously (Babu, et al., 2013). This is unsustainable as the propionate is normally sourced from unnatural sources. <em>E. coli</em> does encode many of the genes needed to produce propionate from glucose, in the Sleeping Beauty Mutase (SBM) operon, which encodes an incomplete pathway for propionate production (Kannan, 2008)</p> | <p style="text-align: justify;">There are many bio-based alternatives to the widely used petrochemical-based plastics, which are degradable and therefore are less damaging to the environment, and to health. One such ‘bio-plastic’ are polyhydroxyalkanoates (PHAs), which is a large family with a huge range of properties. However, only one type of microbe produced PHA is affordable – poly(3- hydroxybutyrate) (PHB) – but too brittle for widespread use. PHA co-polymers, such as poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) are more flexible, and could fill niches that PHB does not. However, producing PHBV by microbes typically needs propionate to be supplied exogenously (Babu, et al., 2013). This is unsustainable as the propionate is normally sourced from unnatural sources. <em>E. coli</em> does encode many of the genes needed to produce propionate from glucose, in the Sleeping Beauty Mutase (SBM) operon, which encodes an incomplete pathway for propionate production (Kannan, 2008)</p> | ||
<p><strong><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/b/b7/T--Edinburgh_OG--PHBV_prodxn_-_5.png" width="1004" height="582" /></strong></p> | <p><strong><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/b/b7/T--Edinburgh_OG--PHBV_prodxn_-_5.png" width="1004" height="582" /></strong></p> | ||
− | <p style="text-align: center;"><strong>Figure | + | <p style="text-align: center;"><strong>Figure 1 </strong>Proposed mechanism for propionate synthesis utilising the Sleeping beauty mutase operon (SBM) and Methylmalonyl-CoA epimerase (MCE) - Succinyl-CoA is converted into Methylmalonyl-CoA-R by the methylmalonyl- CoA mutase ScpA. Methylmalonyl-CoA-R is converted into Methylmalonyl-CoA-S by MCE or an uncharacterised, native pathway. Methylmalonyl-CoA-S is converted into propionyl-CoA by the methylmalonyl-CoA carboxylase ScpB. The CoA from Propionyl-CoA is transferred onto Succinate from the citric acid cycle by the Propionyl-CoA: Succinate CoA transferase ScpC, resulting in the production of propionate and Succinyl-CoA.</p> |
<p> </p> | <p> </p> | ||
<h3><strong>Aim</strong></h3> | <h3><strong>Aim</strong></h3> | ||
Line 566: | Line 568: | ||
<h3><strong>Results and Discussion</strong></h3> | <h3><strong>Results and Discussion</strong></h3> | ||
<p style="text-align: justify;"><strong><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/d/d0/T--Edinburgh_OG--PHBV_prodxn_-_6.png" width="279" height="359" /></strong></p> | <p style="text-align: justify;"><strong><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/d/d0/T--Edinburgh_OG--PHBV_prodxn_-_6.png" width="279" height="359" /></strong></p> | ||
− | <p style="text-align: center;"><strong>Figure | + | <p style="text-align: center;"><strong>Figure 2 </strong>Analytical digest of pSB3T5: SBM using <em>Xba</em>I and <em>Spe</em>I, followed by gel electrophoresis – Uncut sample showed 2 bands, one above 10kbp, and one between 8kbp – 6kbp. XbaI and SpeI single digests show a single band of 8790bp. XbaI and SpeI double digest shows two bands: a pSB3T5 backbone at 3250bp, and the SBM operon at 5540bp</p> |
<p><strong><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/c/cd/T--Edinburgh_OG--PHBV_prodxn_-_7.png" width="504" height="332" /></strong></p> | <p><strong><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/c/cd/T--Edinburgh_OG--PHBV_prodxn_-_7.png" width="504" height="332" /></strong></p> | ||
− | <p style="text-align: center;"><strong>Figure | + | <p style="text-align: center;"><strong>Figure 3 </strong>Colony PCR of 7 colonies of pSB3T5: MCE: SBM – Samples 5, 6, and 7 all have bands between 6kbp – 8kbp, suggesting that they do possess PSB3T5: MCE: Sbm, but would have to be verified by sequencing. </p> |
<h3><strong>Future Work</strong></h3> | <h3><strong>Future Work</strong></h3> | ||
<p style="text-align: justify;">In this work, constructs containing the SBM operon and MCE were developed. The constructs produced in this work need to be verified by sequencing, in order to determine whether there are any mutations that may impact their function.</p> | <p style="text-align: justify;">In this work, constructs containing the SBM operon and MCE were developed. The constructs produced in this work need to be verified by sequencing, in order to determine whether there are any mutations that may impact their function.</p> | ||
<p><strong> </strong></p> | <p><strong> </strong></p> | ||
<h3><strong>References</strong></h3> | <h3><strong>References</strong></h3> | ||
+ | <ul> | ||
<li>Babu, R., O'Connor, K. & Seeram, R., 2013. Current progress on bio-based polymers and their future trends. <em>Progress in Biomaterials,</em>2(1), p.8.</li> | <li>Babu, R., O'Connor, K. & Seeram, R., 2013. Current progress on bio-based polymers and their future trends. <em>Progress in Biomaterials,</em>2(1), p.8.</li> | ||
<li>Kannan, S., 2008. Studies on Methylmalonyl-CoA Mutase from <em>Escherichia coli</em>. Doctoral Dissertation. <em>University of Westminster. </em></li> | <li>Kannan, S., 2008. Studies on Methylmalonyl-CoA Mutase from <em>Escherichia coli</em>. Doctoral Dissertation. <em>University of Westminster. </em></li> | ||
− | + | </ul> | |
</div> | </div> |
Revision as of 01:12, 18 October 2018